These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9147106)

  • 1. Roles of follicle stimulating hormone and luteinizing hormone in controlled ovarian hyperstimulation.
    Hillier SG
    Hum Reprod; 1996 Nov; 11 Suppl 3():113-21. PubMed ID: 9147106
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of follicle-stimulating hormone for controlled ovarian hyperstimulation in in vitro fertilization.
    Navot D; Rosenwaks Z
    J In Vitro Fert Embryo Transf; 1988 Feb; 5(1):3-13. PubMed ID: 3130451
    [No Abstract]   [Full Text] [Related]  

  • 3. [New histophysiological data on superovulation mechanisms in the rat].
    Geiger JM
    Arch Biol (Liege); 1978; 89(4):419-34. PubMed ID: 573099
    [No Abstract]   [Full Text] [Related]  

  • 4. The relationship between circulating concentration of AMH and LH content in the follicle stimulating hormone (FSH) preparations on follicular growth and ovulatory response to superovulation in water buffaloes.
    Redhead AK; Siew N; Lambie N; Carnarvon D; Ramgattie R; Knights M
    Anim Reprod Sci; 2018 Jan; 188():66-73. PubMed ID: 29175175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine and follicle characteristics of cycles with and without endogenous luteinizing hormone surges during superovulation induction with pulsatile follicle-stimulating hormone.
    Messinis IE; Templeton AA
    Hum Reprod; 1987 Jan; 2(1):11-6. PubMed ID: 3106404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative roles of exogenous and endogenous follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in human follicular maturation and ovulation induction.
    Berger MJ; Taymor ML; Karam K; Nudemberg F
    Fertil Steril; 1972 Nov; 23(11):783-90. PubMed ID: 5082616
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of luteinizing hormone in human follicular maturation and function.
    Berger MJ; Taymor ML
    Am J Obstet Gynecol; 1971 Nov; 111(5):708-10. PubMed ID: 5113890
    [No Abstract]   [Full Text] [Related]  

  • 8. The hormonal induction of ovulation or of luteinization in the intact of hypophysectomized guinea-pig.
    Donovan BT; Lockhart AN
    J Endocrinol; 1974 Feb; 60(2):285-92. PubMed ID: 4815983
    [No Abstract]   [Full Text] [Related]  

  • 9. [Gonadotrophins and induction of (super)ovulation].
    Schoot BC; Vemer HM; Fauser BC
    Ned Tijdschr Geneeskd; 1992 Feb; 136(5):217-20. PubMed ID: 1736141
    [No Abstract]   [Full Text] [Related]  

  • 10. Ovarian manipulation with pure gonadotrophins.
    Hillier SG
    J Endocrinol; 1990 Oct; 127(1):1-4. PubMed ID: 2129430
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of intrafollicular injection of hormones and drugs.
    Nalbandov AV; Kao LW; Jones EE
    J Reprod Fertil Suppl; 1973 Jul; 18():15-22. PubMed ID: 4353730
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of intrafollicular injection of gonadotrophins on ovulation or luteinization of ovarian follicle.
    Jones EE; Nalbandov AV
    Biol Reprod; 1972 Aug; 7(1):87-93. PubMed ID: 5050153
    [No Abstract]   [Full Text] [Related]  

  • 13. LH and ovulation induction.
    Filicori M
    Hum Reprod; 2001 Apr; 16(4):803-5. PubMed ID: 11278238
    [No Abstract]   [Full Text] [Related]  

  • 14. Responsiveness of follicles to gonadotropins during estrous cycle in the rat.
    Ying SY; Greep RO
    Endocrinology; 1971 Jul; 89(1):294-7. PubMed ID: 5104441
    [No Abstract]   [Full Text] [Related]  

  • 15. Amounts of interstitial cell-stimulating hormone and follicle-stimulating hormone required for follicular development, uterine growth and ovulation in the hypophysectomized rat.
    Lostroh AJ; Johnson RE
    Endocrinology; 1966 Nov; 79(5):991-6. PubMed ID: 5926168
    [No Abstract]   [Full Text] [Related]  

  • 16. Does supplementation with recombinant luteinizing hormone prevent ovarian hyperstimulation syndrome in down regulated patients undergoing recombinant follicle stimulating hormone multiple follicular stimulation for IVF/ET and reduces cancellation rate for high risk of hyperstimulation?
    Caserta D; Lisi F; Marci R; Ciardo F; Fazi A; Lisi R; Moscarini M
    Gynecol Endocrinol; 2011 Nov; 27(11):862-6. PubMed ID: 21391759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First established pregnancy after controlled ovarian hyperstimulation with recombinant follicle stimulating hormone and the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462).
    Itskovitz-Eldor J; Kol S; Mannaerts B; Coelingh Bennink H
    Hum Reprod; 1998 Feb; 13(2):294-5. PubMed ID: 9557825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteinzing hormone activity in menotropins optimizes folliculogenesis and treatment in controlled ovarian stimulation.
    Filicori M; Cognigni GE; Taraborrelli S; Spettoli D; Ciampaglia W; Tabarelli De Fatis C; Pocognoli P; Cantelli B; Boschi S
    J Clin Endocrinol Metab; 2001 Jan; 86(1):337-43. PubMed ID: 11232021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicle-stimulating hormone/luteinizing hormone ratio as an independent predictor of response to controlled ovarian stimulation.
    Kofinas JD; Elias RT
    Womens Health (Lond); 2014 Sep; 10(5):505-9. PubMed ID: 24807379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superovulation strategy before in vitro fertilization.
    Hillier SG; Afnan AM; Margara RA; Winston RM
    Clin Obstet Gynaecol; 1985 Sep; 12(3):687-723. PubMed ID: 3933880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.